Company Filing History:
Years Active: 2023
Title: The Innovations of Inventor Chea Ha Kim
Introduction
Chea Ha Kim is an innovative inventor based in Seoul, South Korea, known for his significant contributions to the field of cell therapy. With a focus on enhancing the proliferation of regulatory T cells, his research and inventions are paving the way for advancements in medical treatments.
Latest Patents
Chea Ha Kim holds a patent for a composition aimed at culturing regulatory T cells. His invention, titled "Composition for culturing regulatory T cells and use thereof," outlines a method for effectively proliferating regulatory T cells. The method utilizes a fusion protein dimer comprising IL-2 protein or a variant and CD80 protein or a fragment. This approach allows for the effective proliferation of CD4+, CD25+, and CD127- T cells. Notably, it has been observed that this method significantly enhances cell survival rates compared to conventional culture methods using IL-2, and increases the yield of Foxp3+ regulatory T cells. The implications of this proliferation method have considerable potential for the development of cell therapeutic agents using regulatory T cells.
Career Highlights
Chea Ha Kim’s career is marked by his commitment to advancing cellular technologies that can significantly impact therapeutic applications. As a member of Gi Cell, Inc., he is engaged in cutting-edge research and innovation. His work stands at the intersection of immunology and therapeutic interventions, making him a key player in the development of novel medical solutions.
Collaborations
Throughout his career, Chea Ha Kim has collaborated with esteemed colleagues Myoung Ho Jang and Chun-Pyo Hong. These partnerships have fostered an environment of innovation, allowing for the exchange of ideas and knowledge that propel their collective work toward advancements in cell therapy.
Conclusion
Chea Ha Kim's innovative spirit and dedication to research exemplify the role of inventors in shaping the future of medical science. Through his patented methods and collaborative efforts, he is contributing to significant breakthroughs in the proliferation of regulatory T cells, promising enhanced therapeutic options for various health conditions. The impact of his work is expected to resonate in the field of cell therapy for years to come.